JAKSTAT-Target
@jakstattarget
Followers
191
Following
100
Media
57
Statuses
316
Individualized therapy options and strategies to predict treatment response for patients with mature T-cell leukemias/lymphomas. Funded by @ERANET_PerMed
Joined March 2016
Check out our submission for the @ERANET_PerMed video competition summarizing 3 years of work with the @JAKSTATtarget Consortium! Great video editing by our MSc student @bilalsaqib_. The winner will be decided by Youtube likes, so please like and share! https://t.co/3ZPd1YtlfV
1
7
14
Ianevski et al. 2021, from the Aittokallio group at @FIMM_UH Patient-tailored design for selective co-inhibition of leukemic cell subpopulations
0
0
3
Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte Signature by Kelkka et al. 2020 from @hruh_research @TRIMMprogram
https://t.co/ZrZexjrOvE
frontiersin.org
Rheumatoid arthritis (RA) is a complex autoimmune disease targeting synovial joints. Traditionally, RA is divided into seropositive (SP) and seronegative (SN...
0
0
4
Presenting some publications from work conducted by the JAK-STAT Target consortium Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine by Pützer et al. 2020
pubmed.ncbi.nlm.nih.gov
Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine
0
0
1
Stay up to date on more exciting research progress from this multidisciplinary initiative to advance new #JAKSTAT-targeted therapeutics for T-cell leukemias/lymphomas at the @JAKSTATtarget consortium website: https://t.co/A3LHLRAxOQ
0
2
3
New publication from the project! The neonatal microenvironment programs innate γδ T cells through the transcription factor STAT5:
0
1
4
New insights regarding future therapies for human immunological diseases:
0
0
2
New version of #SynergyFinder, a widely used web-tool for interactive analysis and visualization of drug combination screening data, now available. Updated tool published by Group Aittokallio @FIMM_UH @HiLIFE_helsinki in @NAR_Open. #datascience
helsinki.fi
The popular web-application SynergyFinder for interactive analysis and visualization of drug combination screening data has been extensively upgraded. The novel features support especially higher-o...
0
5
4
News from JAKSTAT-Target: New version of the SynergyFinder webtool available! New features support higher-order combination data analytics and exploratory visualization of multi-drug synergy patterns
helsinki.fi
The popular web-application SynergyFinder for interactive analysis and visualization of drug combination screening data has been extensively upgraded. The novel features support especially higher-o...
0
0
0
Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine
0
1
2
JAKSTAT-TARGET is a collaboration between PIs Satu Mustjoki @hruh_research, @Patrick_Gunning @GunningLabUofT, Marco Herling from @UniCologne, Tero Aittokallio lab from @FIMM_UH, @bhaibeka lab from @UHN, and Heidi Neubauer lab from @VetmeduniVienna and funded by #erapermed
0
4
9
This old Twitter account is now taken over by JAKSTAT-Target consortium project which aims to create individualized therapy options and strategies to predict treatment response for patients with mature T-cell leukemias/lymphomas
0
0
3
Apply now for the #CeMMPostdocProgram in Vienna, that includes two interesting potential projects in the group of Kaan Boztug, one focusing on Precision pediatric oncology and the other on Organoid-omics.
APPLY NOW for the #CeMMPostdocProgram in Vienna, offering 13 positions to candidates who are eager to pursue groundbreaking biomedical research and to become future scientific leaders. Pre-ERC Postdoc Program in Cellular, Molecular and Digital Medicine https://t.co/07Czh7P11H
0
2
5
meduniwien.ac.at
0
4
6
Everyone @LBI_CR wishes our followers a wonderful holiday season and a succesful New Year. The instute will be integrated into our partners @MedUni_Wien and @VetmeduniVienna, thus as of 2018 the institute comes to its scheduled end.
0
0
2
We had an exciting 14 years in a time cancer research saw fantastic developments. It was great to have the opportunitiy to contribute with the support of so many collaborators and partners. Thank you all for your support. But now it is time to say goodbye!
0
0
8
check the new website @viennabiocenter
Today we are launching a cool, new website for Vienna BioCenter and for Vienna BioCenter Core Facilities (VBCF): https://t.co/a5gQVv4xiL Two in one! New design, new structure, new content... Check it out! @viennabiocenter
0
1
2
How is life on the cell surface? Many models and diagrams show the cell surface as stiff and unmovable barrier between cells and the outside. But imagine cell membranes are an extremely thin fluid layer of a fatty substance (lipids), which forms a barrier. #biolution #cell
0
6
17
Congratulations to our collaborator @georg_e_winter @CeMM_News for this distinction!
0
0
0
We depict the components of the HIV virion, research revealed fascinating insights into gene regulation and the immune system. While modern therapy allows infected individuals to live a widely normal life nowadays, many challenges remain. @worldaidsday #ROCKTHERIBBON #HIV
1
2
4